NEW ! More discussions & opinions on the latest findings presented.Each Hot Line presentations will be followed by a discussant review which will launch discussions with the panel of experts and the audience on the latest findings presented.These sessions will be held in Room Amsterdam (Central Village).Sunday 1 September11:00 - 12:30 Hot Line I: Late Breaking Trials on Thrombosis 14:00 - 15:30 Hot Line II: Late Breaking Trials on Intervention and devices
Monday 2 September11:00 - 12:30 Hot Line III: Late Breaking Trials on Risk factors and Diabetes Tuesday 3 September11:00 - 12:30 Hot Line IV: Late Breaking Trials on Heart Failure and Acute Coronary Syndrome
NEW ! More discussions & exchange on the Clinical TrialsClinical Trial presentations will be followed by a brief discussant editorial to launch discussions with the panel of experts.Monday 2 September14:00 - 15:30 Clinical Trial Update Hot Line I: Updates on hypertension, heart failure and diabetes - Room Amsterdam (Central Village)Tuesday 3 September11:00 - 12:30 Clinical Trial Update Hot Line II: Updates on intervention and devices - Room Skopje (Village 5)Wednesday 4 September08:30 - 10:00 Clinical Trial Update Hot Line III: Updates on risk and outcome - Room Amsterdam (Central Village)
NEW – Fast Paced presentation of the key elements of the registries followed by one-to-one discussions.The registry presenters will have 5 minutes to present and ample time for with continued discussions on plasma screens around the room for the last part of the session, moderated and animated by chairpersons.Sessions take place in The Hub (Baku) Central Village - an area designed for interactive sessions.
Tuesday 3 September13:00 - 14:15 Registries on risks, therapies and outcomes - 14:30 - 15:45 Registries on prevention and treatment -
Also - Don' t miss on Tuesday 3 September11:00 - 12:30 The cardiovascular scenario in Europe: the ESC EurObservational Research Programme - Room Chisinau (Central Village)A session dedicated to ESC registries including the ongoing registries and their present results conducted in the context of the EurObservational Research Programme (EORP) by the ESC and its Constituent Bodies.The first large scale results of the ongoing ESC registries and the designs of the forthcoming observational studies.
These sessions will present the latest and “hottest” findings of studies in basic and translational cardiovascular science; including cellular, molecular and genetic research and functional studies in genetically engineered mice and larger mammals.Fast-Paced Presentations followed by discussions around plasma screens.Sessions take place in The Hub (Baku) Central Village - an area designed for interactive sessions.Sunday 1 September08:30 - 10:00 Basic and Translational Science Hot Line I – Vascular research - Monday 2 September12:45 - 14:00 Basic and Translational Science Hot Line II – Cardiac research -
Your chance to interact directly with six Late Breaking Trial presenters!
Sunday 1 September15:40-16:20 Treatment of venous thromboembolism, the Hokusai VTE study - Room Damascus (Central Village)15:40-16:20 TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trial - Room Tunis (The Hub-Central Village)
Monday 2 September10:10-10:50 TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy - Room Damascus (Central Village)15:40-16:20 PURE: Contrasting associations between risk factor burden, CVD incidence and mortality in high, middle and low income countries - The PURE sodium study: Sodium Heterogeneity in the associations of urinary sodium and potassium with blood pressure - Room Damascus (Central Village)
Tuesday 3 September
10:10-10:50 PRAMI: Preventive Angioplasty in Myocardial Infarction Trial - Room Damascus (Central Village)
10:10-10:50 SAVOR-TIMI 53 Study: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus - Room Tunis (The Hub-Central Village)up